Compound K Composition for Endogenous Androgen Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need to address the decline in androgen levels associated with aging, which leads to symptoms like late-onset hypogonadism syndrome, and existing androgen replacement therapies have limitations and side effects.

Innovation Solution

A composition containing compound K, a fermentation product of ginseng, or an enzymatically degraded product of ginseng is used to stimulate an increase in androgen levels, specifically testosterone, with optimal concentrations and forms for administration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If androgen replacement therapy is used to treat decreased androgen levels, then androgen levels increase, but liver dysfunction and other side effects occur

Engineering Contradiction:
Improveandrogen levelsVSAvoidliver dysfunction
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent uses compound K as an intermediary substance that indirectly increases androgen levels through stimulation of endogenous production rather than direct replacement. Compound K acts as a mediator that activates the body's own androgen production mechanisms, avoiding the direct toxic effects of exogenous androgens on the liver while still achieving the therapeutic goal of increased androgen levels.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention enables the body's self-service by stimulating endogenous androgen production through compound K administration. Instead of relying on external androgen replacement that causes liver damage, the treatment activates the body's own hormonal production systems, allowing it to generate the needed androgens without the harmful side effects of synthetic replacements.

Inventive Principle:
Principle #25Self-service

2Reliability

If androgen replacement therapy is administered, then symptoms of decreased androgens improve, but the therapy cannot be applied for a long period due to side effects

Engineering Contradiction:
Improvesymptom improvementVSAvoidtherapy duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

Compound K serves as a safe intermediary that enables long-term treatment by indirectly promoting androgen production through endogenous mechanisms. This mediator approach allows sustained therapy duration because compound K itself does not cause the liver toxicity that limits conventional androgen replacement therapy, while still reliably improving androgen-deficiency symptoms over extended periods.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

By activating the body's own androgen production capacity, the treatment enables self-service that can be maintained indefinitely without the accumulation of toxic effects. The body continuously produces androgens in response to compound K stimulation, allowing long-term or even lifelong treatment duration that reliably manages symptoms without the safety constraints of exogenous androgen therapy.

Inventive Principle:
Principle #25Self-service

3Quantity of substance

If conventional androgen replacement is used, then androgen levels are restored, but the treatment lacks safety for long-term use

Engineering Contradiction:
Improveandrogen levelsVSAvoidtreatment safety
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent introduces compound K as a safe intermediary substance that achieves androgen level restoration through indirect stimulation of endogenous production. This mediator mechanism ensures treatment safety because compound K does not carry the liver toxicity associated with direct androgen replacement, while still reliably restoring androgen levels to therapeutic ranges through the body's own production systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The treatment leverages the body's self-service capability to produce androgens endogenously in response to compound K, ensuring long-term safety. By relying on the body's own hormonal production rather than continuous exogenous androgen administration, the treatment achieves reliable androgen level restoration without accumulating the safety risks and liver damage that limit conventional replacement therapy.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS11253532B2Composition for promoting increase in androgen
Publication Date: 2022.02.22 KOBAYASHI PHARMA CO LTD
  • US11253532B2 patent drawing

AI summary

An object of the present invention is to provide a composition for stimulating an increase in an androgen. The composition for stimulating an increase in an androgen contains compound K. The composition for stimulating an increase in an androgen contains a fermentation product and/or enzymatically degraded product of ginseng as an active ingredient.